Stock LSL LSL PHARMA GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

Pharmaceuticals

End-of-day quote Toronto S.E.
Other stock markets
 03:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
0.5 CAD +2.04% Intraday chart for LSL Pharma Group Inc. -1.96% +3.09%
05/06 LSL Pharma to Raise $4.5 Million Via Private Placements MT
05/06 LSL Pharma Group Inc. announced that it expects to receive CAD 3 million in funding CI

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 10.05 8.771 8.214
EBITDA 1 2.513 0.1023 -5.838
EBIT 1 1.682 -0.7078 -6.758
Operating Margin 16.74% -8.07% -82.27%
Earnings before Tax (EBT) 1 0.8232 -1.629 -8.062
Net income 1 0.6099 -1.777 -8.062
Net margin 6.07% -20.26% -98.15%
EPS 2 0.0111 -0.0299 -0.1213
Free Cash Flow - -3.626 0.1085
FCF margin - -41.34% 1.32%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 30/12/22 30/12/22 08/05/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 8.64 12 12.7
Net Cash position 1 - - -
Leverage (Debt/EBITDA) 3.439 x 117.3 x -2.173 x
Free Cash Flow - -3.63 0.11
ROE (net income / shareholders' equity) - -16.6% -96.2%
ROA (Net income/ Total Assets) - -1.57% -15%
Assets 1 - 112.9 53.78
Book Value Per Share 2 0.1900 0.1800 0.0800
Cash Flow per Share 2 0.0400 0.0100 -
Capex 1 3.3 0.91 1
Capex / Sales 32.88% 10.43% 12.14%
Announcement Date 30/12/22 30/12/22 08/05/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
LSL PHARMA GROUP INC. Stock LSL Pharma Group Inc.
+3.09% 3.93Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 77TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 63TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+9.32% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 25TCr
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 22TCr
NOVARTIS AG Stock Novartis AG
+11.88% 22TCr
AMGEN INC. Stock Amgen Inc.
+5.90% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LSL Stock
  4. Financials LSL Pharma Group Inc.